Objectives: It is unclear how many patients with bulimia nervosa (BN) completely abstain from the core behavioral symptoms after receiving psychological treatment. The present meta-analysis of randomized controlled trials (RCTs) aimed to (a) estimate the prevalence of patients who abstain from binge eating and/or purging following all psychological treatments for BN, and (b) test whether these abstinence estimates are moderated by the type of treatment modality delivered, the definition of abstinence applied, and trial quality.
The efficacy of BN treatments reported in previous meta-analyses is usually presented in terms of an effect size, either as the standardized mean difference (SMD) or the odds ratio. The SMD indicates the difference between a treatment and control group in terms of standard deviation units, while the odds ratio indicates the ratio of the odds of an event occurring in the treatment group to the ratio of the event in the control group (Lipsey & Wilson, 2001) . Effect sizes like the SMD and odds ratio produce only relative outcomes, meaning that they can only be understood in relation to the specific control condition administered (Cuijpers et al., 2014) . For example, an odds ratio of 1 indicates that an event such as remission was equally likely to occur in the treatment and control group. However, this odds ratio provides no information on how many patients actually achieved remission after receiving a particular treatment, or on the likelihood of patients not meeting diagnostic criteria for BN following treatment. Consequently, effect sizes like these have been criticized on the grounds that they are not a particularly useful indicator of the clinical importance of a treatment (Cuijpers et al., 2014) .
Abstinence from core BN symptoms (e.g., binge eating, purging) is a widely used and clinically relevant component of a definition of a good treatment outcome, with current evidence supporting the inclusion of abstinence in the definition of recovery (Williams, Watts, & Wade, 2012) . Symptom abstinence following BN treatment has been shown to be a robust predictor of better psychological functioning at long-term follow-up (Kordy et al., 2002; Maddocks & Kaplan, 1991) . It also provides a marker of outcome that is easy to compare across different studies, although such comparisons can be complicated when studies apply different criteria for achieving abstinence (e.g., symptom free for 7, 14, or 28 days; Williams et al., 2012) . Use of abstinence is also more easily interpretable than outcomes assessing the degree of symptom reduction, because symptoms may reduce statistically yet still remain at a clinically significant level. Using abstinence as a primary outcome in BN treatment is also recommended by clinical practice guidelines (National Institute of Clinical Excellence, 2017).
At present, no study has employed meta-analytic procedures to estimate the percentage of patients with BN who achieve abstinence after receiving psychological treatment. Providing empirically-derived and weighted abstinence estimates will be clinically relevant to researchers, practitioners, and patients, in terms of assisting with interpretations regarding the effectiveness of current psychological treatments for BN. Thus, the present meta-analysis aimed to (a) estimate the percentage of patients who achieve symptom abstinence across all psychological treatments for BN in RCTs and (b) test whether abstinence rates are moderated by the mode of treatment delivered, the definition of abstinence applied, and quality of the research trial.
| M E TH OD

| Search strategy and study selection
This review was conducted in accordance to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (Moher, Liberati, Tetzlaff, & Altman, 2009 ). Articles were searched (November 2017) in four online databases by the first author: PsycINFO, Medline, CINAHL, and the Cochrane Library. The following terms were used to search for keywords, titles, and abstracts: "bulimia nervosa", bulimi* AND psychotherap*, therap*, treat*, intervention*,"self help", self-help, "self care", self-care, counsel*, bibliotherap* AND random*, trial*, RCT, controlled, allocat*, assign. Relevant reviews on BN treatment and the reference list of included studies were also searched.
After the search results from the four databases were combined into a single library, duplicate records were removed. Title and abstracts of records were then screened. If a study appeared to meet the inclusion criteria, the full text was read by the first author. Studies were included if (a) it was a published RCT, (b) that included a psychotherapy condition, (c) to individuals with BN, and (d) reported an outcome of behavioral symptom abstinence and the number of patients who achieved abstinence at either post-treatment or follow-up. Consistent with earlier reviews, psychotherapy was defined as an intervention in which the central element was verbal communication between a client and a clinician, or as a psychological treatment in the form of a book or a website which the participant worked through somewhat independently but with guided support from a clinician (Cuijpers et al., 2014; Linardon, Wade, De la Piedad Garcia, & Brennan, 2017b) . Thus, pure self-help interventions and studies that combined a psychological and pharmacological intervention were excluded.
| Quality assessment
The validity of included trials was assessed using the Cochrane Risk of Bias tool (Higgins & Green, 2011) . This tool assesses potential sources of biases in RCTs, including the adequate generation of allocation sequence, the concealment of allocation to treatment conditions, blinding of outcome assessors or the use of self-report questionnaires, and the handling of incomplete data. The first author and an independent research assistant conducted the quality assessment. Ratings between assessors were cross-checked, and any discrepancy was resolved by discussion.
| Meta-analytic procedure
To estimate the percentage of patients who achieved abstinence, the pooled event rate (i.e., the number of patients who abstained in one psychotherapy condition divided by the total number of patients in that condition), weighted by the sample size, was calculated using the procedures outlined by Borenstein, Hedges, Higgins, and Rothstein (2009) . Pooled event rates were calculated for all patients randomized to treatment (intention-to-treat; ITT) and again for only those who completed treatment (if completer data were reported). For our purpose, it was assumed that the dropouts did not achieve abstinence (as done previously by Hay, Bacaltchuk, Stefano, & Kashyap, 2009 ).
All analyses were performed using comprehensive meta-analysis.
Since heterogeneity was expected, random effects models were used.
The degree of heterogeneity was assessed through the I 2 statistic (Higgins & Thompson, 2002) . I 2 can range from zero (no heterogeneity) to 100 (complete heterogeneity).
A series of subgroup (moderator) analyses was also conducted to explain potential sources of heterogeneity. For the subgroup analyses, a pooled event rate was calculated for each subgroup, and a test was conducted to determine whether the event rates for subgroups differed significantly from each other. A mixed effects model was used, which pools studies within a subgroup using a random effects model, but tests for significant differences (denoted by Q bp ) between subgroups using a fixed effects model (Borenstein et al., 2009 ).
The impact of potential publication bias was also tested using Duval and Tweedie's trim and fill procedure. This procedure produces an estimate of the event rate after publication bias has been taken into account (or corrected for), by calculating adjusted values of the pooled event rates and 95% confidence intervals (Duval & Tweedie, 2000) .
| R E SU LTS
3.1 | Study characteristics Most included trials (36) defined abstinence as the complete cessation of objective binge eating and all purging behaviors. Of these 36 trials, one trial used a 3-month criterion of being symptom-free for achieving abstinence, 25 trials used a 28-day criteria, one trial used a 14-day criteria, 6 trials used a 7-day criteria, and three trials did not specify the timeframe needed to be considered abstinent. Fewer trials (8) defined abstinence as the complete cessation of purging only, with 4 of these using a 28-day criteria, one using a 21-day criterion, two using a 7-day criteria, and one trial not specifying the timeframe required.
One trial defined abstinence as the complete cessation of binge eating only (with a 28-day criteria). From all 45 trials, 33 used a semistructured interview to assess treatment outcome (24 used the Eating 3.2 | Post-treatment abstinence rates Weighted abstinence rates are also presented for each psychotherapy type in Table 1 . For the ITT analysis, abstinence rates across psychotherapies ranged from 20 to 40%, with behavior therapy producing the highest abstinence rate and interpersonal psychotherapy producing the lowest abstinence rate. For the completer analysis, abstinence rates ranged from 12 to 47%, with behavior therapy again producing the highest abstinence rate and family therapy producing the lowest abstinence rate (see Table 1 ).
| Subgroup analyses
Results from the subgroup analyses at post-treatment are presented in Table 2 . A number of significant moderators emerged. First, in both ITT and completer analyses, guided self-help treatments were associated with significantly lower abstinence rates than individual and groupbased clinician-led treatments. Second, in ITT analyses, abstinence rates were highest when abstinence was defined as the cessation of symptoms within the last 14 days, as opposed to last 21, 28 days, or 3 months. Third, in ITT and completer analyses, abstinence rates were highest when abstinence was defined in terms of binge-eating cessation, as opposed to purging cessation, or binge eating and purging Note. CBT 5 cognitive-behavioral therapy; N cond 5 number of psychotherapy conditions.
cessation. The number of treatment sessions and trial quality did not emerge as significant moderators (Table 2 ). Follow-up abstinence rates are also presented for each psychotherapy type. For the ITT analysis, abstinence rates across psychotherapies ranged from 10% (nonspecific supportive therapies) to 35% (family-based therapy). For the completer analysis, abstinence rates across psychotherapies ranged from 13% (non-specific supportive therapies) to 41% (family-based therapy). Subgroup analyses were not performed for follow-up event rates because of the relatively smaller number of trials that reported follow-up data (and hence many subgroups contained too few studies to allow for a meaningful comparison).
| Follow-up abstinence rates
| Sensitivity analysis
Given that the definition of abstinence varied widely across trials, we performed a sensitivity analysis in which we only analyzed trials that defined abstinence as the cessation of binge eating and purging within the last 28 days. This sensitivity analysis can be seen in Table 3 . As seen, the pooled event rate for the ITT analysis was 23.2% (95% CI 5 19.2, 27.6) and the pooled event rate for the completer analysis was 27.8% (95% CI 5 22.0, 34.5). Treatment modality emerged as a significant moderator in the ITT sensitivity analysis, where individual clinician-led treatment produced a significantly higher abstinence estimate than group-based clinician-led treatment and guided self-help treatment.
| D ISC USSION
The aims of this meta-analysis were to estimate average rate of abstinence from RCTs of BN treatment, and to identify factors that moderate these abstinence estimates. This study found that 35% of treatment completers achieved abstinence at post-treatment. The same estimate for treatment completers was observed at follow-up (35%), suggesting that psychological treatments for BN have an enduring effect. Abstinence rates derived for all randomized patients (i.e., including dropouts) were, however, slightly lower at both posttreatment (30%) and follow-up (29%). We also found evidence that abstinence rates were typically highest in trials that administered behavioral-based treatments (e.g., CBT, behavior therapy). Overall, the present findings indicate that around a third of patients with BN completely cease binge eating and/or purging after receiving psychological treatment.
Several important factors were also shown to moderate the abstinence estimates. Estimates were highest in studies that used a shorter duration for defining abstinence (i.e., 14 days symptom free over 28 days days). Under shorter timeframes, abstinence estimates are likely to be inflated, as shorter timeframes (14 days or fewer) fail to capture the fluctuations in symptoms that are typical in BN (Williams et al., 2012) . Since 28-days symptom-free is generally the accepted timeframe for defining abstinence-which is the timeframe employed by the widely used Eating Disorder Examination-interpretations of the present estimates should be primarily based on bulk of trials (68% of trials) that used 28-day symptom-free as the criteria for achieving abstinence. It is interesting to note that the event rate for the subgroup of trials that used the 28-day criteria (completer 5 26%, ITT 5 32%)
was only slightly lower than the overall event rate (completer 5 30%,
ITT 5 35%). Nevertheless, to obtain a more accurate estimate of the percentage of patients who achieve abstinence, it is important for future trials to define abstinence using the 28-day or three month symptom-free criteria over the 7 or 14-day criteria.
Another important moderating variable was the type of treatment modality delivered, where post-treatment abstinence estimates were significantly lower in guided self-help interventions than in clinician-led treatments. This effect cannot be explained by any differences in the amount of therapist contact provided (i.e., guided treatments are typically shorter in duration than clinician-led treatments), as no relationship was observed between the number of treatment sessions and abstinence rates. Rather, it may be that patients with BN respond better and more quickly to intensive treatments in which the clinician, rather than the patient themselves, directs and leads the nature, content, and course of therapy. Given that similar abstinence estimates were observed between treatment modalities at follow-up, it is likely that guided self-help is a slower acting intervention that merely takes longer to achieve its therapeutic effects.
The present findings highlight the urgency toward improving the effectiveness of psychological treatments for BN. Although many patients with BN may show some improvements during therapy, this study found that >60% do not abstain from core behavioral symptoms following even the most empirically-supported treatments. Improving the effectiveness of BN treatment is therefore an important research priority. As highlighted in numerous reviews (Kazdin, 2007; Kraemer, Wil- This meta-analysis has important limitations. First, many of the subgroups within the subgroup analyses contained few studies, so it is was likely that some effects were not detected due to insufficient statistical power. Second, the length of follow-up varied across trials. For example, some trials reported data for three month follow-up and others reported data for 12 month follow-up. The limited number of trials that conducted follow-up assessments prevented estimates of abstinence rates at different follow-up lengths. Third, because only RCTs were included, the present estimates cannot be generalized to abstinence rates expected from patients treated in "real world" settings. Fourth, a moderate to high degree of heterogeneity was present in our most of our analyses, even after we tried to account for this through several subgroup
analyses. This suggests that there may be other important study-level moderators (e.g., sample demographics, comorbidity rates, illness severity and duration, therapist experience etc.) that are impacting these abstinence rates. It is therefore important for future research to seek to understand all possible patient, study, therapist, and treatment characteristics that moderate these abstinence estimates. Finally, only published trials were included, so there is a possibility that some unpublished trials of psychological treatment for BN were missed.
In sum, the present meta-analysis demonstrated that just over a third of patients who receive psychological treatments for BN achieve abstinence from binge eating and purging. There was evidence to suggest that abstinence rates were lowest in guided self-help treatments.
The fact that >60% of patients fail to fully abstain from core BN symptoms highlights the importance of improving the effectiveness of psychological treatments for this population. 
